{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:08:16Z","timestamp":1783609696375,"version":"3.55.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP.02\/534\/44"],"award-info":[{"award-number":["RGP.02\/534\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.yexcr.2025.114434","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T16:15:14Z","timestamp":1738772114000},"page":"114434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies"],"prefix":"10.1016","volume":"445","author":[{"given":"Ali G.","family":"Alkhathami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikumar","family":"Pallathadka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7664-4086","authenticated-orcid":false,"given":"Sejal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-7428","authenticated-orcid":false,"given":"Yasser Fakri","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Qasim","family":"Alasheqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed J.","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8031-8083","authenticated-orcid":false,"given":"Ahmed Hussein","family":"Zwamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yexcr.2025.114434_bib1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","article-title":"Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study","volume":"17","author":"Rizzo","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.yexcr.2025.114434_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-021-01313-x","article-title":"Non-coding RNAs regulation of macrophage polarization in cancer","volume":"20","author":"Mohapatra","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2025.114434_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","article-title":"Long non-coding RNAs in the doxorubicin resistance of cancer cells","volume":"508","author":"Ashrafizaveh","year":"2021","journal-title":"Cancer Lett."},{"issue":"Pt 3","key":"10.1016\/j.yexcr.2025.114434_bib4","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.semcancer.2021.09.007","article-title":"Microbiota and prostate cancer","volume":"86","author":"Rizzo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114434_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112963","article-title":"Long non-coding RNAs and exosomal lncRNAs: potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling","volume":"150","author":"Entezari","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"15","key":"10.1016\/j.yexcr.2025.114434_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512253","article-title":"Long noncoding RNAs in taxane resistance of breast cancer","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib7","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1038\/s41598-024-55210-6","article-title":"Non-coding RNA-related FCGBP downregulation in head and neck squamous cell carcinoma: a novel biomarker for predicting paclitaxel resistance and immunosuppressive microenvironment","volume":"14","author":"Ding","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114434_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.795613","article-title":"Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1\/STAT3\/FUT4 Axis and P-glycoprotein transporters in lung cancer cells","volume":"13","author":"Ding","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114434_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111172","article-title":"Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment","volume":"134","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114434_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111172","article-title":"Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment","volume":"134","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12935-024-03415-0","article-title":"Key genes and molecular mechanisms related to Paclitaxel Resistance","volume":"24","author":"Alalawy","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12032-024-02577-1","article-title":"LncRNAs in modulating cancer cell resistance to paclitaxel (PTX) therapy","volume":"42","author":"Alkhathami","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexcr.2025.114434_bib13","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.2147\/OTT.S147586","article-title":"LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194","volume":"10","author":"An","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.yexcr.2025.114434_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1257941","article-title":"Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC","volume":"15","author":"Chang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114434_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102429","article-title":"Immunotherapy in pancreatic cancer: why do we keep failing? A focus on tumor immune microenvironment, predictive biomarkers and treatment outcomes","volume":"14","author":"Di Federico","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114434_bib16","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.7150\/jca.39463","article-title":"LncRNA NONHSAT141924 promotes paclitaxel chemotherapy resistance through p-CREB\/Bcl-2 apoptosis signaling pathway in breast cancer","volume":"11","author":"Gu","year":"2020","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib17","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s12253-019-00718-w","article-title":"LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway","volume":"26","author":"Guo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"21","key":"10.1016\/j.yexcr.2025.114434_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213689","article-title":"Prognostic value of neutrophil-to-eosinophil ratio (NER) in cancer: a systematic review and meta-analysis","volume":"16","author":"Sahin","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib19","first-page":"1","article-title":"LncRNAs in modulating cancer cell resistance to paclitaxel (PTX) therapy","volume":"42","author":"Alkhathami","year":"2025","journal-title":"Med. Oncol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114434_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","article-title":"Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data","volume":"31","author":"Guven","year":"2023","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.yexcr.2025.114434_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2018.09.018","article-title":"Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway","volume":"359","author":"Han","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114434_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.809410","article-title":"A novel miR-98 negatively regulates the resistance of endometrial cancer cells to paclitaxel by suppressing ABCC10\/MRP-7","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00280-020-04120-1","article-title":"HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer","volume":"86","author":"Jiang","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114434_bib24","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.33398","article-title":"Epigenetic regulation of cancer stem cell formation and maintenance","volume":"148","author":"French","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114434_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103141","article-title":"HOTAIR beyond repression: in protein degradation, inflammation, DNA damage response, and cell signaling","volume":"105","author":"Price","year":"2021","journal-title":"DNA Repair"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/cbdd.14006","article-title":"Multiple function of lncRNA MALAT1 in cancer occurrence and progression","volume":"101","author":"Malakoti","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.yexcr.2025.114434_bib27","first-page":"1","article-title":"Dysregulation of GAS5\u2013miRNA-mediated signaling pathways in cancer pathobiology: a comprehensive exploration of pathways influenced by this Axis","author":"Oghenemaro","year":"2024","journal-title":"Biochem. Genet."},{"issue":"23","key":"10.1016\/j.yexcr.2025.114434_bib28","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/cancers13235874","article-title":"The miR-200 family of microRNAs: fine tuners of epithelial-mesenchymal transition and circulating cancer biomarkers","volume":"13","author":"Cavallari","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2025.114434_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13058-021-01491-y","article-title":"Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1","volume":"23","author":"Liu","year":"2021","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114434_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154566","article-title":"Pathological role of long non-coding (lnc) RNA in the regulation of Wnt\/\u03b2-catenin signaling pathway during epithelial-mesenchymal transition (EMT)","volume":"248","author":"Alsaab","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12665","article-title":"Regulatory role of long non-coding RNA UCA1 in signaling pathways and its clinical applications","volume":"21","author":"Liu","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2025.114434_bib32","article-title":"The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2025.114434_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2021.10.011","article-title":"Circulating RNAs in prostate cancer patients","volume":"524","author":"Mugoni","year":"2022","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib34","article-title":"Downregulation of HULC induces ferroptosis in hepatocellular carcinoma via targeting of the miR\u20103200\u20105p\/ATF4 axis","volume":"2022","author":"Guan","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12967-024-05554-4","article-title":"A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer","volume":"22","author":"Grillone","year":"2024","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41420-022-01174-3","article-title":"Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance","volume":"8","author":"Zhu","year":"2022","journal-title":"Cell death discovery"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27207","article-title":"Long non-coding RNAs in drug resistance across the top five cancers: update on their roles and mechanisms","volume":"10","author":"Shi","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/iub.2888","article-title":"lncRNAs: new players of cancer drug resistance via targeting ABC transporters","volume":"76","author":"Ebrahimnezhad","year":"2024","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/17425255.2021.1887139","article-title":"The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer","volume":"17","author":"Wang","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.canlet.2016.08.015","article-title":"Long non-coding RNA UCA1 promotes cisplatin\/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells","volume":"382","author":"Pan","year":"2016","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114434_bib42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/1120009X.2023.2177807","article-title":"LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma","volume":"35","author":"Jin","year":"2023","journal-title":"J. Chemother."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib43","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15384047.2020.1829266","article-title":"LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p\/FKBP1A axis","volume":"21","author":"Leng","year":"2020","journal-title":"Cancer Biol. Ther."},{"issue":"10","key":"10.1016\/j.yexcr.2025.114434_bib44","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/1061186X.2019.1585437","article-title":"NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt\/mTOR signalling pathway","volume":"27","author":"Li","year":"2019","journal-title":"J. Drug Target."},{"issue":"21","key":"10.1016\/j.yexcr.2025.114434_bib45","doi-asserted-by":"crossref","first-page":"24171","DOI":"10.18632\/aging.203672","article-title":"LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p\/MTDH pathway-mediated autophagy and genomic instability","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib46","first-page":"364","article-title":"[Effects of lncRNA RP11-770J1.3 and TMEM25 expression on paclitaxel resistance in human breast cancer cells]","volume":"46","author":"Li","year":"2017","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib47","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12639","article-title":"Knockdown of long non-coding RNA DDX11-AS1 inhibits the proliferation, migration and paclitaxel resistance of breast cancer cells by upregulating microRNA-497 expression","volume":"25","author":"Liang","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"23","key":"10.1016\/j.yexcr.2025.114434_bib48","first-page":"8903","article-title":"Paclitaxel-resistant related lncRNA DBH-AS1 promotes the proliferation and invasion of esophageal cancer","volume":"26","author":"Lin","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.yexcr.2025.114434_bib49","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/CMAR.S241969","article-title":"Long non-coding RNA UCA1 modulates paclitaxel resistance in breast cancer via miR-613\/CDK12 Axis","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2217\/pgs-2022-0121","article-title":"DDX11-AS1 modulates DNA damage repair to enhance paclitaxel resistance of lung adenocarcinoma cells","volume":"24","author":"Liu","year":"2023","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib51","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4103\/aja2021117","article-title":"LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p\/STK4 pathway in prostate cancer","volume":"24","author":"Lu","year":"2022","journal-title":"Asian J. Androl."},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib52","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1002\/jcp.26383","article-title":"LncRNA MALAT1 induces colon cancer development by regulating miR\u2010129\u20105p\/HMGB1 axis","volume":"233","author":"Wu","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2025.114434_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106418","article-title":"Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy","volume":"184","author":"Hashemi","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/abbs\/gmy022","article-title":"LncRNAs in DNA damage response and repair in cancer cells","volume":"50","author":"Su","year":"2018","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-023-00395-1","article-title":"LINP1 represses unfolded protein response by directly inhibiting eIF2\u03b1 phosphorylation to promote cutaneous squamous cell carcinoma","volume":"12","author":"Liang","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12885-023-10593-z","article-title":"LncRNA ANRIL promotes HR repair through regulating PARP1 expression by sponging miR-7-5p in lung cancer","volume":"23","author":"Du","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-020-01175-9","article-title":"Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance","volume":"19","author":"Bhat","year":"2020","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib58","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s13577-022-00768-4","article-title":"The role of lincRNA-p21 in regulating the biology of cancer cells","volume":"35","author":"Huang","year":"2022","journal-title":"Hum. Cell"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib59","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ijc.34040","article-title":"The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma","volume":"151","author":"Liao","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114434_bib60","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1007\/s10571-023-01414-9","article-title":"Function of long noncoding RNAs in glioma progression and treatment based on the wnt\/\u03b2-catenin and PI3K\/AKT signaling pathways","volume":"43","author":"Li","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.yexcr.2025.114434_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114434_bib62","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/pgs-2022-0011","article-title":"Talazoparib in BRCA-mutated advanced breast cancer: is earlier better?","volume":"23","author":"Boulos","year":"2022","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.yexcr.2025.114434_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118725","article-title":"The landscape of long non-coding RNAs in tumor stroma","volume":"264","author":"Uddin","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10585-022-10192-5","article-title":"PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization","volume":"40","author":"Zhang","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114434_bib65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-020-02820-3","article-title":"Antisense oligonucleotides targeting lncRNA AC104041. 1 induces antitumor activity through Wnt2B\/\u03b2-catenin pathway in head and neck squamous cell carcinomas","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/acsami.8b18288","article-title":"Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis","volume":"11","author":"Gong","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib67","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12943-023-01765-3","article-title":"HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer","volume":"22","author":"Raju","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","article-title":"LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling","volume":"23","author":"Luo","year":"2024","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.yexcr.2025.114434_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e36469","article-title":"LncRNA HIF1A-AS2 promotes triple-negative breast cancer progression and paclitaxel resistance via MRPS23 protein","volume":"10","author":"Min","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexcr.2025.114434_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148900","article-title":"lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel","volume":"932","author":"Naseri","year":"2025","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib71","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3892\/or.2016.4981","article-title":"Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma","volume":"36","author":"Ren","year":"2016","journal-title":"Oncol. Rep."},{"issue":"18","key":"10.1016\/j.yexcr.2025.114434_bib72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2217\/pgs-2022-0077","article-title":"lncRNA MALAT1 regulates the resistance of breast cancer cells to paclitaxel via the miR-497-5p\/SHOC2 axis","volume":"23","author":"Shi","year":"2022","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.yexcr.2025.114434_bib73","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.12659\/MSM.910932","article-title":"LINC01118 modulates paclitaxel resistance of epithelial ovarian cancer by regulating miR-134\/ABCC1","volume":"24","author":"Shi","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.yexcr.2025.114434_bib74","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2017.09.026","article-title":"Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy","volume":"267","author":"Wang","year":"2017","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3233\/CBM-181573","article-title":"Downregulation of long noncoding RNA PVT1 attenuates paclitaxel resistance in glioma cells","volume":"23","author":"Song","year":"2018","journal-title":"Cancer Biomarkers"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib76","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1002\/jcb.26901","article-title":"HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib77","doi-asserted-by":"crossref","first-page":"275","DOI":"10.32604\/or.2022.03561","article-title":"PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16\/CEBPB\/GATA3 axis","volume":"29","author":"Wang","year":"2021","journal-title":"Oncol. Res."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib78","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2018.05.104","article-title":"UCA1 confers paclitaxel resistance to ovarian cancer through miR-129\/ABCB1 axis","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.yexcr.2025.114434_bib79","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1039\/D1BM00879J","article-title":"Platinum-based chemotherapy via nanocarriers and co-delivery of multiple drugs","volume":"9","author":"Xian","year":"2021","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2006.03.001","article-title":"In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors","volume":"112","author":"Koziara","year":"2006","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib81","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1038\/cddis.2011.139","article-title":"Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells","volume":"3","author":"Ajabnoor","year":"2012","journal-title":"Cell Death Dis."},{"issue":"34","key":"10.1016\/j.yexcr.2025.114434_bib82","doi-asserted-by":"crossref","first-page":"23875","DOI":"10.1074\/jbc.274.34.23875","article-title":"A \u03b2-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance\u2217 210","volume":"274","author":"Gonzalez-Garay","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114434_bib83","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/15384101.2017.1301334","article-title":"LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a\/CPEB2 axis","volume":"16","author":"Wang","year":"2017","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib84","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1111\/jcmm.13679","article-title":"Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206\/ABCB1","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib85","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2025.114434_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147230","article-title":"Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b","volume":"860","author":"Wei","year":"2023","journal-title":"Gene"},{"issue":"15","key":"10.1016\/j.yexcr.2025.114434_bib87","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1111\/jcmm.15487","article-title":"LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C\/EBP\u03b2","volume":"24","author":"Wu","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib89","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41419-019-2063-6","article-title":"Activation of Piezo1 sensitizes cells to TRAIL-mediated apoptosis through mitochondrial outer membrane permeability","volume":"10","author":"Hope","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114434_bib90","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2174\/157489211796957739","article-title":"Therapeutic targeting of CD95 and the TRAIL death receptors","volume":"6","author":"Gerspach","year":"2011","journal-title":"Recent Pat. Anti-Cancer Drug Discov."},{"key":"10.1016\/j.yexcr.2025.114434_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120328","article-title":"KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG\/CLDN6 signaling in epithelial ovarian cancer","volume":"293","author":"Wu","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib92","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","article-title":"LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis","volume":"35","author":"Xu","year":"2023","journal-title":"J. Chemother."},{"key":"10.1016\/j.yexcr.2025.114434_bib93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00432-003-0430-1","article-title":"p53 expression and resistance against paclitaxel in patients with metastatic breast cancer","volume":"129","author":"Schmidt","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib94","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/127681","article-title":"Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K\/AKT signaling pathway","volume":"29","author":"Li","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.yexcr.2025.114434_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002620050605","article-title":"Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-\u03baB-and AP-1-dependent mechanism","volume":"49","author":"Collins","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib96","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-019-1017-z","article-title":"Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer","volume":"18","author":"Xu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib97","doi-asserted-by":"crossref","first-page":"10541","DOI":"10.1080\/21655979.2021.1999555","article-title":"Long non-coding RNA (LncRNA) SNHG7\/Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib98","first-page":"316","article-title":"LncRNA KB-1471A8.2 overexpression suppresses cell proliferation and migration and antagonizes the paclitaxel resistance of ovarian cancer cells","volume":"34","author":"Zhang","year":"2019","journal-title":"Cancer Biother. Radiopharm."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jb\/mvaa036","article-title":"LncRNA SDHAP1 confers paclitaxel resistance of ovarian cancer by regulating EIF4G2 expression via miR-4465","volume":"168","author":"Zhao","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.yexcr.2025.114434_bib100","article-title":"Paclitaxel resistance modulated by the interaction between TRPS1 and AF178030.2 in triple-negative breast cancer","volume":"2022","author":"Zhao","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.yexcr.2025.114434_bib101","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/IJWH.S7012","article-title":"Clinical trials and progress with paclitaxel in ovarian cancer","author":"Kumar","year":"2010","journal-title":"Int. J. Wom. Health"},{"issue":"21","key":"10.1016\/j.yexcr.2025.114434_bib102","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.3390\/jcm13216537","article-title":"Next-generation immunotherapy: advancing clinical applications in cancer treatment","volume":"13","author":"Garg","year":"2024","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114434_bib103","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.3390\/ijerph19074260","article-title":"Predicting response to anthracyclines in ovarian cancer","volume":"19","author":"Ferrero","year":"2022","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib104","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.annonc.2021.06.004","article-title":"Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer","volume":"32","author":"Sugawara","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.yexcr.2025.114434_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105320","article-title":"Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications","volume":"163","author":"Zeng","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114434_bib106","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s43094-024-00638-w","article-title":"Prevention of paclitaxel-induced peripheral neuropathy: literature review of potential pharmacological interventions","volume":"10","author":"Mahmoud","year":"2024","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib107","first-page":"202","article-title":"lncRNA-PRLB confers paclitaxel resistance of ovarian cancer cells by regulating RSF1\/NF-\u03baB signaling pathway","volume":"36","author":"Zhao","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib108","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/1440-1681.13758","article-title":"LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p\/PIK3C3 mediated autophagy","volume":"50","author":"Zheng","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib109","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/abbs\/gmab098","article-title":"lncRNA NEAT1 promotes the Taxol resistance of breast cancer via sponging the miR-23a-3p-FOXA1 axis","volume":"53","author":"Zhu","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2025.114434_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.702082","article-title":"The role of non-coding RNAs in breast cancer drug resistance","volume":"11","author":"Tian","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib111","first-page":"784","article-title":"The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors","volume":"4","author":"Goebel","year":"2021","journal-title":"Cancer Drug Resistance"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/1120009X.2021.1906032","article-title":"Overexpression of long non-coding RNA urothelial carcinoma associated 1 causes paclitaxel (Taxol) resistance in colorectal cancer cells by promoting glycolysis","volume":"33","author":"Shi","year":"2021","journal-title":"J. Chemother."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib113","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/medicina58111660","article-title":"Glutathione transferase P1: potential therapeutic target in ovarian cancer","volume":"58","author":"Simic","year":"2022","journal-title":"Medicina"},{"issue":"23","key":"10.1016\/j.yexcr.2025.114434_bib114","doi-asserted-by":"crossref","DOI":"10.7150\/thno.49922","article-title":"Managing therapeutic resistance in breast cancer: from the lncRNAs perspective","volume":"10","author":"Peng","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114434_bib115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13258-021-01093-0","article-title":"Propofol enhanced the cell sensitivity to paclitaxel (PTX) in prostatic cancer (PC) through modulation of HOTAIR","volume":"43","author":"Yang","year":"2021","journal-title":"Genes & genomics"},{"key":"10.1016\/j.yexcr.2025.114434_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2023.147230","article-title":"Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b","volume":"860","author":"Wei","year":"2023","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2025.114434_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.693259","article-title":"The emerging role of non-coding RNAs in drug resistance of ovarian cancer","volume":"12","author":"Lan","year":"2021","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114434_bib118","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2018.05.104","article-title":"UCA1 confers paclitaxel resistance to ovarian cancer through miR-129\/ABCB1 axis","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2025.114434_bib119","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/OTT.S240434","article-title":"Long noncoding RNA TUG1 promotes autophagy-associated paclitaxel resistance by sponging miR-29b-3p in ovarian cancer cells","author":"Gu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114434_bib120","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.ajpath.2019.07.020","article-title":"Long noncoding RNA LINC01133 confers tumor-suppressive functions in ovarian cancer by regulating leucine-rich repeat kinase 2 as an miR-205 sponge","volume":"189","author":"Liu","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"24","key":"10.1016\/j.yexcr.2025.114434_bib121","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel\u2013carboplatin alone or with bevacizumab for non\u2013small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.yexcr.2025.114434_bib122","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/cancers14092101","article-title":"The mechanisms of lncRNA-mediated multidrug resistance and the clinical application prospects of lncRNAs in breast cancer","volume":"14","author":"Ye","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.yexcr.2025.114434_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2018.09.018","article-title":"Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway","volume":"359","author":"Han","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib124","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1016\/j.bj.2020.11.002","article-title":"LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570\u20133p","volume":"44","author":"Yue","year":"2021","journal-title":"Biomed. J."},{"key":"10.1016\/j.yexcr.2025.114434_bib125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtn.2019.05.007","article-title":"lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143\/FOSL2-signaling pathway in ovarian cancer","volume":"17","author":"Li","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114434_bib126","first-page":"3438","article-title":"Tumor-released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non-small cell lung cancer","volume":"40","author":"Lei","year":"2018","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114434_bib127","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/jpm11050420","article-title":"Lincp21-RNA as predictive response marker for preoperative chemoradiotherapy in rectal cancer","volume":"11","author":"Benitez","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.yexcr.2025.114434_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0442-z","article-title":"The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer","volume":"13","author":"Li","year":"2015","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114434_bib129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/1061186X.2017.1307379","article-title":"LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells","volume":"25","author":"Shen","year":"2017","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114434_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263829","article-title":"DNAJB1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling","volume":"17","author":"Kim","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2025.114434_bib131","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2147\/OTT.S234924","article-title":"LncRNA HOTTIP participates in cisplatin resistance of tumor cells by regulating miR-137 expression in pancreatic cancer","author":"Yin","year":"2020","journal-title":"OncoTargets Ther."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725000308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T19:42:23Z","timestamp":1740512543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725000308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0014482725000308"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114434","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms behind the LncRNAs-mediated regulation of paclitaxel (PTX) resistance in human malignancies","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114434"}}